Translation of Quebec Back Pain Disability Scale Into Local Languages of Pakistan.
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Apr 1, 2021
Trial Information
Current as of June 07, 2025
Unknown status
Keywords
ClinConnect Summary
The Quebec Back Pain Disability Scale is a first-hand measure of functional disability for patients with back pain. It distinguishes itself from other published scales as it has an approach that deals with the concepts of disability and its assessment. Its major aim is to be a responsive measure of functional disability in back pain. Quebec back pain disability Questionnaire has unique strong characteristics that are quite feasibly used and have good identification properties regarding Low Back Pain. There is extensive usage, applicability, and validity of QBPDS in research and clinical pra...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients both male and female having age group equal or \>18,
- • should be able to read the questionnaire that is in their native language(Punjabi, Sindhi, Balochi and Pashto) and
- • diagnosed with nonspecific low back pain for more than 3 months.
- Exclusion Criteria:
- • Any serious conditions like neurological conditions which would not allow the patient to fill the questionnaire independently,
- • any infection, tumor, spinal surgery, cognitive impairments, or any other rheumatologic disease would be excluded.
- • Any issues in understanding or expressing the native language (Punjabi, Pashto, Balochi or Sindhi) will be excluded.
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Multan, Punajb, Pakistan
Patients applied
Trial Officials
Imran Amjad, PhD
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials